Partnering for Brain Health: Midi Health and Neurotrack Collaborate to Offer Accurate Cognitive Assessments during Menopause Transition

Midi Health teams up with Neurotrack to assist in detecting cognitive decline during menopause.

A collaboration between Midi Health, a clinic specializing in midlife women’s health, and Neurotrack, a digital cognitive assessment company, aims to help women differentiate between symptoms of brain fog related to menopause and those indicative of more severe cognitive conditions like early dementia. Through this partnership, Midi Health clinicians can administer Neurotrack’s cognitive screening to patients via smartphone, tablet, or computer, significantly reducing the time it takes to complete the test to just three minutes.

Patients who receive low scores on the Neurotrack screening will be referred to healthcare providers for a more detailed evaluation. This partnership aims to provide women with timely and accurate information about their cognitive health, allowing for early detection and intervention if necessary. According to Midi Health’s Chief Medical Officer, Kathleen Jordan, brain fog is a common symptom reported by 74% of their patients going through menopause. However, she notes that experiencing brain fog does not necessarily indicate a higher risk of developing dementia. For most women, the Neurotrack screening can offer reassurance, but for a few, it could lead to early detection of dementia, which benefits from early treatment.

Midi Health recently secured $25 million in Series A funding from Google Ventures to expand its services across the country. Neurotrack raised $10 million in 2022 and has been actively partnering with organizations like insurance provider Nationwide to streamline cognitive health assessments for long-term care underwriting. This collaboration highlights the importance of early cognitive assessment in women’s health during menopause transition by leveraging digital technologies making it easier for women access timely and accurate information about their cognitive well-being ultimately improving outcomes for those at risk of cognitive decline.

The collaboration between Midi Health and Neurotrack underscores how advances in technology are changing healthcare by providing more accessible and efficient ways to diagnose diseases and monitor patient outcomes. As these technologies continue to evolve, they will likely play an increasingly important role in preventative medicine and early intervention strategies.

In conclusion, this partnership between Midi Health and Neurotrack is a step towards improving healthcare outcomes for midlife women by providing them with accessible tools for monitoring their cognitive health during menopause transition. By leveraging digital technologies such as smartphones and tablets for cognitive assessments

Leave a Reply